Topics

8/27/15

Researchers in the lab of David Dietz, PhD, assistant professor of pharmacology and toxicology, discovered an unknown neural pathway that can regulate changes made in the brain from cocaine use. 

9/19/14

Research by David Dietz, PhD, has the potential to identify novel therapies to treat addiction to cocaine and other psychostimulants, for which no effective drug therapy exists.

7/11/14

Research co-authored by Andrew H. Talal, MD, shows that injection drug users who are enrolled in a treatment program want to be educated about hepatitis C virus (HCV) and are willing to be treated.

3/7/14

The risks of the new painkiller Zohydro — an extended-release formulation of hydrocodone — far outweigh the benefits and could lead to more overdoses, according to Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine.

10/9/13

Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine, will direct a new national center aimed at training physicians to address addiction through early intervention and prevention.

11/3/11

With a major grant, family medicine physicians at UB are forming a council that will develop curricula and national standards of excellence for postgraduate medical education programs in addiction medicine.

5/31/11

UB’s addiction medicine residency is one of the first of its kind to be accredited by the American Board of Addiction Medicine Foundation.